Title:
スルホニルカルバマート胆汁酸誘導体の調製のためのプロセス
Document Type and Number:
Japanese Patent JP7136802
Kind Code:
B2
Abstract:
The present invention relates to processes for preparing compounds of Formula (I) and compounds of Formula (II) or a pharmaceutically acceptable salt or solvate thereof. These compounds and pharmaceutical compositions are useful as FXR or TGR5 modulators. Specifically, the present invention relates to bile acid derivatives and methods for their preparation and use. The present invention relates to a process for the preparation of the compounds of Formula (III), Formula (IV), Formula (V), and Formula (VI), The present invention also relates to a process for the preparation of compounds (VII), (VIII) and (IX).
Inventors:
One, Guochang
Hey, Yeon
Granger, Bullet
Shin, Xue Chao
Oru, Yat, Sun
Hey, Yeon
Granger, Bullet
Shin, Xue Chao
Oru, Yat, Sun
Application Number:
JP2019554595A
Publication Date:
September 13, 2022
Filing Date:
April 09, 2018
Export Citation:
Assignee:
Enanta Pharmaceuticals Incorporated
International Classes:
C07J41/00; C07J43/00
Foreign References:
| WO2018152171A1 | ||||
| WO2016161003A1 |
Attorney, Agent or Firm:
Asamura patent office